Agenus (AGEN) Announces Positive Opinion on Glaxo's (GSK) Malaria Vaccine from EMA
Tweet Send to a Friend
Agenus (NASDAQ: AGEN) announced that GlaxoSmithKline (NYSE: GSK) received a positive opinion for its Malaria vaccine candidate from the Committee ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
